Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy

Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy

Show other versions (1)

© 2019 National Academy of Sciences. All rights reserved. Cancer-associated fibroblasts (CAFs) can either suppress or support T lymphocyte activity, suggesting that CAFs may be reprogrammable to an immunosupportive state. Angiotensin receptor blockers (ARBs) convert myofibroblast CAFs to a quiescent...

Full description

Bibliographic Details
Main Authors:	Chauhan, Vikash P, Chen, Ivy X, Tong, Rong, Ng, Mei Rosa, Martin, John D, Naxerova, Kamila, Wu, Michelle W, Huang, Peigen, Boucher, Yves, Kohane, Daniel S, Langer, Robert, Jain, Rakesh K
Format:	Article
Language:	English
Published:	Proceedings of the National Academy of Sciences 2021
Online Access:	https://hdl.handle.net/1721.1/135170

Similar Items

Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy
by: Chauhan, Vikash P., et al.
Published: (2022)

Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
by: Chen, Ivy Xiaoyu, et al.
Published: (2020)

Smart nano-PROTACs reprogram tumor microenvironment for activatable photo-metabolic cancer immunotherapy
by: Zhang, Chi, et al.
Published: (2022)

Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
by: Chauhan, Vikash P., et al.
Published: (2013)

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
by: Diop-Frimpong, Benjamin, et al.
Published: (2011)

Angiotensin receptor blockers and β-blockers in Marfan syndrome: an individual-patient-data meta-analysis of randomised trials
by: Pitcher, A, et al.
Published: (2022)

In vivo discovery of immunotherapy targets in the tumour microenvironment
by: Zhou, Penghui, et al.
Published: (2014)

The effects of adrenaline, angiotensin II, and its blocker on bovine coronary arteries
by: Ku Zaifah, Norsidah
Published: (2003)

Angiotensin II receptor blocker valsartan enhances glucose-induced insulin secretion
by: Ayob, Azizi, et al.
Published: (2006)

Evidence-based treatment of hypertension: What's the role of angiotensin II receptor blockers?
by: Hobbs, R, et al.
Published: (2005)

MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment
by: Wilson, RaeAnna, et al.
Published: (2017)

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
by: McMurray, J, et al.
Published: (2005)

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
by: Xu, J, et al.
Published: (2020)

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.
by: McMurray, J, et al.
Published: (2012)

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
by: Mcmurray, J, et al.
Published: (2012)

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
by: Regev, Aviv
Published: (2022)

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Published: (2021)

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials
by: McAlister, F
Published: (2012)

Estrogen reprograms the activity of neutrophils to foster protumoral microenvironment during mammary involution
by: Chung, Hwa Hwa, et al.
Published: (2018)

Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents, and beta-blockers: an electronic health records network study
by: Harrison, P, et al.
Published: (2020)

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
by: Morales, DR, et al.
Published: (2020)

Sonodynamic Nano-LYTACs reverse tumor immunosuppressive microenvironment for cancer immunotherapy
by: Xu, Mengke, et al.
Published: (2025)

PERBANDINGAN KUALITAS HIDUP PENDERITA GAGAL JANTUNG KRONIK YANG MENDAPATKAN TERAPI ANGIOTENSIN CONVERTING ENZYME INHIBITORS ATAU ANGIOTENSIN II RESEPTOR BLOCKERS DENGAN Î²-BLOCKERDAN TANPA Î²-BLOCKER DI RSUP Dr SARDJITO
by: , DWI PUMP YETTYNINGSIH, et al.
Published: (2013)

Evaluation of angiotensin ii receptor blockers (ARBS) for drug formulary using objective scoring analytical tool.
by: Lim, Ming Tsuey
Published: (2011)

Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases
by: Prakadan, Sanjay M, et al.
Published: (2022)

The roles of CD38 and CD157 in the solid tumor microenvironment and cancer immunotherapy
by: Wo, Yu Jun, et al.
Published: (2020)

Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people
by: Dambha-Miller, H, et al.
Published: (2022)

Angiotensin receptor blockers for erectile dysfunction in hypertensive men: a brief meta-analysis of randomized control trials
by: Ismail, Shaiful Bahari, et al.
Published: (2019)

Inverse opal hydrogel scaffolds as lymphoid microenvironments for the study of immune cell migration and immunotherapy
by: Stachowiak, Agnieszka (Agnieszka N.)
Published: (2007)

A calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduced blood pressure variability in acute ischaemic stroke (CAARBS): a feasibility trial
by: Davison, WJ, et al.
Published: (2020)

Transformable nanosensitizer with tumor microenvironment-activated sonodynamic process and calcium release for enhanced cancer immunotherapy
by: Tan, Xuan, et al.
Published: (2022)

Local Targeting of NAD + Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma
by: Li, Ming, et al.
Published: (2022)

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
by: Hippisley-Cox, J, et al.
Published: (2020)

Metabolomics of beta-blockers
by: Tan, Ian Yong Ming.
Published: (2010)

Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker.
by: Marques, M, et al.
Published: (2012)

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
by: Amoozgar, Zohreh, et al.
Published: (2022)

Randomised controlled trial of a calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduce blood pressure variability following ischaemic stroke (CAARBS): a protocol for a feasibility study
by: Robinson, T, et al.
Published: (2019)

iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
by: Horton, C, et al.
Published: (2019)

Network device ad-blocker
by: Mohamad, Juhaina, et al.
Published: (2020)

Beta-blockers in cardiac failure.
by: Neubauer, G, et al.
Published: (1994)